Details for Patent: 9,527,833
✉ Email this page to a colleague
Which drugs does patent 9,527,833 protect, and when does it expire?
Patent 9,527,833 protects LONSURF and is included in one NDA.
This patent has forty-seven patent family members in twenty-nine countries.
Summary for Patent: 9,527,833
| Title: | Stable crystal form of tipiracil hydrochloride and crystallization method for the same |
| Abstract: | An objective of the present invention is to obtain a stable crystal form of 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione hydrochloride. The present invention provides a crystal of 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione hydrochloride exhibiting characteristic peaks at angles of 11.6.degree., 17.2.degree., 17.8.degree., 23.3.degree., 27.1.degree., and 29.3.degree. as a diffraction angle (2.theta..+-.0.1.degree.) in powder X-ray diffraction. |
| Inventor(s): | Kazuno; Hideki (Ibaraki, JP), Mutsumi; Tomonobu (Saitama, JP) |
| Assignee: | TAIHO PHARMACEUTICAL CO., LTD. (Tokyo, JP) |
| Application Number: | 14/896,748 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,527,833 |
|
Patent Claim Types: see list of patent claims | Compound; Composition; Use; Formulation; |
Drugs Protected by US Patent 9,527,833
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taiho Oncology | LONSURF | tipiracil hydrochloride; trifluridine | TABLET;ORAL | 207981-001 | Sep 22, 2015 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| Taiho Oncology | LONSURF | tipiracil hydrochloride; trifluridine | TABLET;ORAL | 207981-002 | Sep 22, 2015 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,527,833
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2013-126567 | Jun 17, 2013 |
| PCT Information | |||
| PCT Filed | June 17, 2014 | PCT Application Number: | PCT/JP2014/065985 |
| PCT Publication Date: | December 24, 2014 | PCT Publication Number: | WO2014/203877 |
International Family Members for US Patent 9,527,833
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014282281 | ⤷ Try a Trial | |||
| Australia | 2017208215 | ⤷ Try a Trial | |||
| Australia | 2018219967 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
